The pharmaceutical supply chain and device development have become intricately linked. Harmonizing formulation development ...

The light interacts with the cavity and makes an arbitrary number of bounces before leaking out. This emergent light is traditionally treated as heat in quantum simulations. However, it can still be ...

Join Daesang and Mattson for an exclusive Prepared Foods webinar designed for product developers seeking to master sodium reduction without compromising flavor. This technical webinar will explore ...

The Comirnaty 2025-2026 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, a descendant of JN.1. The Food and Drug Administration (FDA) has approved Comirnaty ® (LP.8.1-adapted monovalent ...

CRDMOs offer a continuum of services from early discovery to clinical manufacturing, addressing solubility and stability challenges in NCE development. Advanced technologies like spray drying and ...

Dave Miller, PhD, explains how early formulation planning, novel platforms, and tailored approaches secure long-term protection against generics. In this final part of our 5-part interview series on ...

Agriculture roadmaps can be mainly theoretical papers that lie unused on the shelf. Or they can be living practical documents that guide and motivate actions to increase agriculture productivity and ...

Kashmik Formulation, a pharmaceutical manufacturing company headquartered in Ahmedabad, has announced significant expansion plans aimed at increasing production capacity, strengthening its presence in ...

To optimize the final formulation for a drug, it must meet many criteria beyond producing a safe and effective product. For example, it must be stable and amenable to various manufacturing steps, such ...

Abstract: A novel algorithm for automatic behavioral model topology formulation (MTF) is described in this paper. Several new terms are defined to support this formulation approach. The algorithms for ...

Sarclisa SC formulation added to Pd for the treatment of R/R MM met the co-primary endpoints in the IRAKLIA phase 3 study, demonstrating non-inferiority compared to Sarclisa IV IRAKLIA is the first ...